Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
  1. 4 Grant or award Director acquired 8,933 shares (grant or award)
  2. 4 Exercise or conversion Director acquired 9,469 shares (option exercise)
  3. 4 Open-market buy Director bought 15,000 shares at $3.05 ($45,750)
  4. 4 Open-market buy 10% owner bought 50,000 shares at an average $4.96 ($247,926)
  5. 4 Grant or award Chief Financial Officer acquired 55,556 shares (grant or award)
  6. 4 Grant or award General Counsel acquired 50,000 shares (grant or award)
  7. 4 Grant or award Chief Business Officer acquired 50,000 shares (grant or award)
  8. 4 Grant or award President, Ophthalmology & CMO acquired 63,333 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 186,750 shares (grant or award)
  10. 4 Open-market buy 10% owner bought 5,500 shares at $5.20 ($28,600)
  11. 4 Open-market buy 10% owner bought 74,500 shares at an average $5.45 ($405,808)
  12. 4 Open-market buy 10% owner bought 50,000 shares at an average $6.06 ($302,921)
  13. 4 Open-market buy 10% owner bought 44,490 shares at an average $6.35 ($282,421)
  14. 4 Open-market buy 10% owner bought 40,510 shares at an average $6.61 ($267,796)
  15. 4 Open-market buy 10% owner bought 60,900 shares at an average $6.18 ($376,603)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy President and CEO bought 5,000 shares at $9.89 ($49,450)

Page 9 of 18 · 354 filings